Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/28/2003US20030162205 Novel transcription factor having zinc finger domain
08/28/2003US20030162203 Medical diagnosis using chromosomes, nucleic acids
08/28/2003US20030162200 Methods for modulating telomerase activity
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162189 Adjust gene expression; genetic engineering; antiproliferative agents
08/28/2003US20030162187 Method of detecting sexual differentiation disruptor
08/28/2003US20030162186 Human cDNAs and proteins and uses thereof
08/28/2003US20030162180 Calibrating test pattern; hybrid primers
08/28/2003US20030162177 Human Tbx20 gene and uses
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162172 Polypeptide encoding receptors; medical diagnosis; modulate gene expression
08/28/2003US20030162170 Nucleic acids; antibody, antigen complex
08/28/2003US20030162169 Screening enzyme inhibitors
08/28/2003US20030162168 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
08/28/2003US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay
08/28/2003US20030161897 Soluble plant derived natural color concentrates and antimicrobial nutraceuticals
08/28/2003US20030161889 Microspheres having diameter of 1 nanometer to 10 microns comprised of poly(DL-lactide-co-glycolide) as bulk matrix; immunogenic substance comprising Colony Factor Antigen or hepatitis B surface antigen
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/28/2003US20030161844 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
08/28/2003US20030161840 Immunogensn comprising a long synthetic peptide comprising the epitopes contained within the merozoite surface protein (MSP-3b peptide; vaccine against malaria; parasiticides; in vitro detection of premunition cerebral malaria
08/28/2003US20030161838 A highly purified protein, Plasmodium falciparum MSP-142, which retains folding and disulfide bridging of the native molecule and is useful as a diagnostic reagent, antibody production, and as a vaccine for malaria
08/28/2003US20030161837 Crosslinking an immunoglobulin or fragment thereof with anN-hydroxyl-succinimide ester and a maleimide linked vis a polyethyleneoxide spacer and incubating with a polypeptide having a sulfhydryl group (an allergen or autoantigen)
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161835 Polypeptides from moraxella (branhamella) catarrhalis
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161829 Short peptides of 12-22 amino acids from the CD-74-like domain of Insulin Growth Factor-binding protein-3 mimic the full molecule's co-apoptotic, cell-penetrating and metal-binding properties; side effects reduction; antitumor agents
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161814 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
08/28/2003US20030161809 Complexes; drug delivery
08/28/2003US20030159933 Immobilized to support; diffusion
08/28/2003CA2775650A1 Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods
08/28/2003CA2513192A1 Nucleotide sequence coding for a tolc and a defined amino acid sequence
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2485882A1 A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient
08/28/2003CA2483646A1 Fluorescent protein
08/28/2003CA2480771A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
08/28/2003CA2477202A1 Cd40 splice variants, compositions for making and methods of using the same
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477159A1 Highly homogeneous molecular markers for electrophoresis
08/28/2003CA2477068A1 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476965A1 Method of modulating e-cadherin mediated cell adhesion
08/28/2003CA2476894A1 Transgenic production in saliva
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476761A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003CA2476100A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2473078A1 Method for producing interferon
08/28/2003CA2471410A1 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombinactivator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequences
08/28/2003CA2462133A1 Novel polypeptide
08/28/2003CA2460055A1 Insulin and igf-1 receptor agonists and antagonists
08/28/2003CA2420355A1 Novel polypeptide and process for producing the same
08/28/2003CA2418780A1 Synthetic genes encoding proteins of porcine reproductive and respiratory syndrome virus and use thereof
08/28/2003CA2373903A1 Increasing plant seed production
08/27/2003EP1338896A2 ICAM-4 and diagnostic uses thereof
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338652A2 Plant cell cyclin genes
08/27/2003EP1338651A1 Method of screening remedy for diabetes
08/27/2003EP1338649A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof
08/27/2003EP1338609A1 A further KDR receptor and the use thereof
08/27/2003EP1338608A2 Protein complexes and methods for their use
08/27/2003EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins
08/27/2003EP1338606A1 Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer
08/27/2003EP1337859A1 Selective anxiolytic therapeutic agents
08/27/2003EP1337852A1 A functional assay for g-protein-coupled receptors based on insect cells
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337653A2 Controlled environment agriculture bioreactor for heterologous protein production
08/27/2003EP1337647A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/27/2003EP1337646A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
08/27/2003EP1337645A2 Rhodococcus cloning and expression vectors
08/27/2003EP1337644A2 Aspergillus fumigatus profilin
08/27/2003EP1337643A1 Manipulation of plant life cycles and/or growth phases
08/27/2003EP1337642A1 Cytokin-like proteins
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337638A2 Adipocyte complement related protein zacrp13
08/27/2003EP1337637A2 Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337635A2 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337627A2 Method for purifying adenoviruses
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337559A2 Regulation of human nmda receptor
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337557A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
08/27/2003EP1337556A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
08/27/2003EP1337555A2 Mutant bcl-2 proteins and uses thereof
08/27/2003EP1337554A2 Novel compounds
08/27/2003EP1337553A2 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
08/27/2003EP1337552A2 Light-driven energy generation using proteorhodopsin
08/27/2003EP1337546A2 Method for detecting hematopoietic stem cells
08/27/2003EP1337545A2 Antisense modulation of src-1 expression
1 ... 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 ... 2916